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Abstract
Background Gastric banding still represents one of the
most widely used bariatric procedures. It provides accept-
able weight loss in many patients, but has frequent long-
term complications. Because different types of bands may
lead to different results, we designed a randomized study to
compare the Lapband® with the SAGB®. We hereby report
on the long-term results.
Methods Between December 1998 and June 2002, 180 mor-
bidly obese patients were randomized between Lapband® or
SAGB®. Weight loss, long-term morbidity, and need for
reoperation were evaluated.
Results Long-term weight loss did not differ between the two
bands. Patients who maintained their band had an acceptable
long-termweight loss of between 50 and 60%EBMIL. In both
groups, about half the patients developed long-term complica-
tions, with about 50% requiringmajor redo surgery. There was
no difference in the overall rates of long-term complications or
failures between the two groups, but patients who had a
Lapband® were significantly more prone to develop band
slippage/pouch dilatation (13.3 versus 0 %, p <0,001).
Conclusions Although in the absence of complication, gas-
tric banding leads to acceptable weight loss; the long-term
complication and major reoperation rates are very high
independently from the type of band used or on the oper-
ative technique. Gastric banding leads to relatively poor
overall long-term results and therefore should not be con-
sidered the procedure of choice for the treatment of morbid
obesity. Patients should be informed of the limited overall
weight loss and the very high complication rates.
Keywords Bariatric surgery . Gastric banding . Obesity .
Complications
Introduction
Obesity, and especially morbid obesity, has become a wide-
spread phenomenon in most western countries. Epidemiologic
studies show an amplification of the current trends with a
prediction of obesity prevalence reaching 30 % among Euro-
pean adults in 2015 similar to the situation in the USA now-
adays. Severe obesity-associated comorbidities lead to im-
paired overall health status, reduced quality of life, and higher
mortality, especially from cardiovascular causes and cancer. In
the absence of efficient medical therapies, bariatric surgery
remains the form of treatment that is both efficient and dura-
ble. Before the laparoscopic era, bariatric surgery was
regarded by many patients and physicians as a dangerous tool
associated with a relatively high risk of complications. Most
bariatric procedures are currently performed by laparoscopy,
which has largely contributed to a reduction in surgery-related
morbidity and mortality. As a consequence, we currently face
a rapidly increasing demand for bariatric surgery both from
patients and their doctors.
Gastric banding (GB) was the first laparoscopic bariatric
procedure [1, 2]. Its early surgical morbidity and mortality
were rapidly shown to be minimal, especially when com-
pared to those of open bariatric procedures like vertical
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banded gastroplasty, the operation most commonly
performed in Europe at the time of its introduction [3].
This lead to a rapid gain of its popularity during the mid
1990s. After very enthusiastic initial results, however, it
became apparent that sufficient weight loss could not al-
ways be achieved and that long-term complications arose
after some time in a significant proportion of the patients,
leading to band deflation with weight regain or reoperations
[4–7]. To reduce the rate of pouch dilatation and slippages,
one of the most common complications in the early days,
the surgical technique was modified with the introduction
of the pars flaccida technique. Bands were also improved in
both their construction and design, and protocols for patient
follow-up and band adjustment were developed using not
only weight loss as a base for band adjustment but also
other factors such as food tolerance, hunger, and satiety.
Except for one study that showed a lower posterior pouch
dilatation rate with the new technique [8], the literature is
still lacking hard data showing if all these modifications
have resulted in significant improvement of the results.
In 1998, when GB was still and by far our procedure of
choice to treat morbid obesity, we designed a prospective
randomized trial with the intention to compare the results of
the two bands that were available at the time, the Lapband®
(Bioenterics, Carpinteria, California, USA, now Allergan) and
the Swedish Adjustable Gastric Band (SAGB®) (Obtech Med-
ical, Zug, now Ethicon Endosurgery). Our hypothesis at this
time was that the softer band (SAGB), which had a larger
balloon, would result in better food tolerance, allow for finer
band adjustments, and perhaps result in better weight loss. Our
early results, reported in 2005 [9], failed to show any significant
difference between the two bands up to the 3-year term, both in
terms of weight loss as of complications. All patients have now
been followed for at least 10 years, with an average of 12 years.
In this paper, we now report on long-term results of this study.
Patients and Methods
Patients and Randomization
Participation in this study was proposed between December
1998 and June 2002 to all patients scheduled for laparo-
scopic gastric banding. All patient were fully evaluated by a
multidisciplinary team specialized in the management of
morbid obesity. They also underwent preoperative upper
gastrointestinal endoscopy and echography. Most patients
were also submitted to 24 h baseline pH monitoring and
esophageal manometry. Exclusion criteria were severe re-
flux disease, large hiatus hernia (>2 cm), redo bariatric
surgery, and patient's refusal and contraindications to lapa-
roscopy. Patients with a large hiatus hernia (>2 cm) or
severe reflux were offered Roux-en-Y gastric bypass. The
protocol was accepted by the local ethics committee on
November 9, 1998. Informed consent was obtained from
all patients. Randomization was done using numbered
sealed envelopes, which were opened immediately before
surgery. To facilitate interim analysis, the envelopes were
grouped so that there would be an equal number of patients
in each study arm after every ten patients.
Primary and Secondary Endpoints
The primary endpoint was weight loss as this is the first
goal of any bariatric procedure. Secondary endpoints were
early and late complications, reoperations, the proportion of
patients with an excess BMI loss (EBMIL) of at least 50 %
(success rate in terms of weight loss), and the overall failure
rate (EBMIL <25 % or band removal ± conversion to
another bariatric procedure). Power calculations suggested
that at least 81 patients would be needed in each group to
identify a 10 % difference in the percentage of EBMIL,
with a power of 80 % at the 5 % significance level. With
the same power and significance levels, it was also calcu-
lated that at least 307 patients would be required in each
group to identify a 50 % reduction in the long-term com-
plication rates (from 16 % as observed during our early
experience (excluding the learning curve) to 8 %).
Operative Procedures
We had performed a total of 144 GB before we initiated this
study, 98 with the Lapband®, and 46 with the SAGB® so that
the learning curve was therefore behind us. The same surgeon
performed himself or participated in all the procedures. Pro-
phylactic antibiotics (amoxicillin clavulanate 2.2 g or
cefuroxim 1.5 g) were administered as a single dose at the
induction of anesthesia. Thromboembolic prophylaxis was
provided using low molecular weight heparin which started
at the induction of anesthesia and was maintained until the end
of the fourth postoperative week.
The surgical technique has been described in details else-
where [5]. The Lapband® was placed using the perigastric
technique, which was still the prevailing technique when the
study began in 1998, and the SAGB®was placed according to
the pars flaccida technique. In all cases, care was taken to
place the band above the lesser omental sac. When using the
perigastric technique, if the lesser sac was entered during
dissection, a new retrogastric tunnel was created higher up.
All bands were secured anteriorly with four gastro-gastric
sutures. The band was left empty at the end of the procedure.
Postoperative Care
The patients followed a semiliquid diet for the first postoper-
ative month, after which a barium swallow was performed to
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assess the position of the band. The first band inflation was
usually done at this time. The patients were then instructed to
follow a well-balanced solid diet, to take small bites, to chew
well, to eat slowly, to avoid drinking while eating, and to
avoid sparkling drinks. Further, band adjustments were
performed as necessary during follow-up, depending on the
patient's weight loss, eating capacities, sensation of hunger
and satiety, and sometimes radiological and/or endoscopic
appearance. The maximal capacity of the band (5 ml for the
Lapband® and 9 ml for the SAGB®) was strictly respected.
Patients were seen every month for the first semester, every
2 months during the second semester, quarterly the second
year, biannually up to 5 years, and at least yearly thereafter.
Barium swallows were routinely repeated after 12–18months,
after 3 years, and then every 2 years or if mandated by an
abnormal clinical course. Gastroscopy was used liberally in
patients with symptoms suggesting a possible problem.
Long-term complications were divided into two catego-
ries. Major complications were either life-threatening or
lead to band removal, while minor complications included
revisions maintaining the band in place. Patients whose
band had to be removed and/or who were converted to
another bariatric procedure were excluded from further
weight loss analysis. However, for the purpose of an
intention-to-treat analysis, they remained included in the
analysis regarding the percentage of patients achieving an
EBMIL of at least 50 % in which they were considered as
failures as of the time of band removal or conversion.
Evaluation of Results
The percentage of EBMIL and the body mass index (BMI)
were used to evaluate weight loss [10]. As a BMI of 25
represents the upper limit for normal weight, this was consid-
ered as corresponding to the ideal weight. Excess BMIwas the
difference between the actual BMI and 25. The percentage of
patients reaching an EBMIL of at least 50 % (therapeutic
success) was also calculated. Failure was defined as an
EBMIL <25 % or the need for band removal/conversion.
Showing weight loss results only in patients who retain their
band, however, gives a wrong impression of the overall re-
sults. In order to depict the latter in a more realistic way, a
separate “intention-to-treat” analysis was performed with the
evolution of BMI over time. In the latter, the initial BMI was
carried forward as of the time of reoperation in patients who
required band removal.
Statistical Analysis
Comparisons between groups were made using the Stu-
dent's t test or the Mann–Whitney U test for continuous
variables. The Chi-square test with Yates correction, if
necessary, or the Fisher's exact test were used for
categorical variables as appropriate. Differences were con-
sidered significant with p ≤0.05.
Results
One hundred eighty patients of 181 eligible patients were
included in the study between December 1998 and June
2002 at which time patient recruitment was stopped (see
flow chart, Fig. 1). At that time, laparoscopic Roux-en-Y
gastric bypass had largely replaced gastric banding as the
primary bariatric procedure of choice at our institution. A
single patient refused to participate. The preoperative char-
acteristics did not differ between groups, except for age,
which was 3 years older in the Lapband® group (Table 1).
All patients received the allocated intervention. Ninety pa-
tients in group A received a Lapband®, and 90 patients in
group B received a SAGB®. Early results, including early
morbidity, have been published previously [1] and this
report focuses only on long-term results.
The mean duration of follow-up was 144 months. At the
time of analysis, four patients had died from causes
unrelated to obesity or to the procedure. All the remaining
patients had a follow-up of at least 10 years, with 166
(94.3 %) available for analysis at this term. There was no
significant difference in follow-up rates between the two
groups. One hundred eight (92.3 %) out of 117 eligible
patients were available at 12 years.
The two groups had very similar results in terms of weight
loss. Figure 2 depicts the results in terms of EBMIL, and Fig. 3
shows the evolution of the mean BMI. Patient who still had
their band in place maintained an average EBMIL of 50–60 %
throughout the study period. Weight loss was faster in group A
than in group B, but the difference disappeared after 2 years. In
order to provide a perspective of the overall results regarding
weight loss, taking into account the fact that band removal is in
Fig. 1 Flow chart of patient accrual during the study period (RYGBP
Roux-en-Y gastric bypass)
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most cases associated with progressive weight regain unless
another procedure is performed, we also calculated the mean
BMI at each term in an “intention-to-treat” analysis, where the
initial BMI was carried forward as of the time of reoperation in
patients who required band removal (Fig. 4).
Long-term complications were very common in both
groups and continued to develop over time (Table 2). There
was a significant difference between the two groups with
respect to pouch dilatation ± slippage, which developed in
13 % of the patients after Lapband® compared with none in
the SAGB group (p <0.001). The incidences of all other
individual complications were similar between groups, and
there was no difference in the overall incidence of long-
term complications. Major long-term complications leading
to band removal were common, with a 50 and 48.9 %,
respectively, after Lapband and SAGB.
A high number of reoperations were required during the
follow-up period. Most band- or port-related minor compli-
cations were corrected under local anesthesia (port/tubing
problems). Many patients eventually required band remov-
al, with or without conversion to another bariatric proce-
dure (Table 3).
The total failure rate (Fig. 5), defined as either the need for
major reoperations or failure to achieve sufficient weight loss
(EBMIL <25%), increased over time in both groups with rates
between 50 and 60 % after 10 years. The total failure rate was
higher at all time points in group B, with a significant differ-
ence up to 4 years. This was due in part to faster weight loss in
group A in part to a higher incidence of major complications
during early follow-up in group B. The difference, however,
lost statistical significance as of the fifth postoperative year.
Discussion
The long-term follow-up results of this randomized trial
showed that (a) long-term weight loss is similar with the
Lapband® or the SAGB® in patient who retain their band,
(b) both bands are associated with high long-term compli-
cation and reoperation rates, and (c) GB with either band
has a high long-term failure rate.
GB is a short and relatively simple laparoscopic proce-
dure which preserves the digestive tract. It has low periop-
erative morbidity and almost no mortality. It can be
performed on an outpatient basis, in many cases, is adjust-
able and reversible. As such, GB could be perceived as the
ideal operation for high-risk morbidly obese patients. It
works essentially as a purely restrictive procedure even
though some authors recently theorized that it did not
provide true restriction (the passage of food is not slowed
down) but instead a rapid sensation of satiety, possibly
mediated by the vagus nerve, caused by the esophagus
squeezing food through the band [11].
Since the introduction of laparoscopic adjustable GB,
two main bands, with their subsequent modifications, have
been used: the Lapband® and the SAGB®, with their sub-
sequent modifications. Several other models are currently
available on the market, although not approved in every
Fig. 2 Excess BMI loss (EBMIL): comparison between Lapband®
and SAGB®. *p <0.05; **p <0.001
Fig. 3 Evolution of BMI with SD. Comparison between Lapband®
and SAGB®. *p <0.05; **p <0.01
Table 1 Preoperative patient's
characteristics Lapband (A) SAGB (B) p value
Weight (extremes) 116.1 kg (79.4–161) 119.9 kg (87.5–165) 0.11
BMI (extremes) 42.6 kg/m2 (34.4–55.6) 43.4 kg/m2 (34.3–51.6) 0.18
Excess weight 92.5 % (54–155) 97.3 (52–137) 0.17
Age 39.5 years (22–64) 36.3 years (19–62) 0.03
Comorbidities 82.2 % 84.4 % NS
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country. The Lapband® that was used in this study is a rigid
and relatively narrow (12.5 mm) silicone band with an
inner balloon that can be inflated up to 5 ml according to
the manufacturer. It is described as a high-pressure band
since the pressure created within the balloon rapidly in-
creases to values well above 150 kPa [7]. The SAGB® is
a soft silicone band that is much wider (23 mm) with a
balloon that can be inflated up to 9 ml and is described as a
low pressure system since the inner pressure of the balloon
remains relatively low even with maximal inflation. Some
of the differences between these two bands could theoreti-
cally account for differences in results. The greater volume
of the SAGB® could make fine adjustment easier, with low
pressure on the gastric wall, thereby providing better food
tolerance, reduced vomiting/regurgitation, and possibly in-
crease weight loss. Its wide design could reduce the pres-
sure transmitted to the gastric wall, resulting in fewer
erosions, and also help avoiding band slippage. On the
other hand, the Lapband® with its smooth and narrow inner
surface could increase the risk of erosion and slippage. To
the best of our knowledge, the present study is the first
randomized trial comparing these two devices and provid-
ing long-term (>10 year) results.
Patients who retained their band maintained on average
an EBMIL of between 50 and 60 %, which is considered
acceptable according to bariatric standards and compares
well to long-term results of other procedures such as Roux-
en-Y gastric bypass [12, 13]. Unfortunately, and sometimes
only several years after surgery, many patients eventually
developed long-term complications. This often leads to
band deflation in an attempt to reduce side effects (poor
food tolerance, heartburn, regurgitation, and pulmonary
symptoms) or directly to band removal (erosion or infec-
tion). The problem is that the majority of patients in whom
the band needs to be deflated regain weight progressively
despite further education or dietary counseling. Most of
them eventually ask for a tighter band adjustment again.
Our policy in these cases is to re-inflate the band very
slowly and by very small increments to prevent recurrence
of side effects/complications, with radiological and/or en-
doscopic surveillance if necessary notably to assess reversal
of esophageal dilatation/dysmotility or esophagitis. Experi-
ence, however, shows that complications or side effects
tend to slowly return over time with a tighter band, leading
to patient's dissatisfaction despite renewed weight loss. In
the majority of cases, a time comes when we have to
discuss with the patient between accepting insufficient
weight loss with adequate quality of life and minimal side
effects or aiming for better weight loss with conversion to
another procedure, which represents a failure for the band
in terms of intention-to-treat. While success, which should
be defined as a combination of acceptable weight loss,
resolution/improvement of comorbidities and improvement
of quality of life, is often achieved in the absence of
complication, this high long-term complication rate is of
great concern, with a 50–60 % 10-year failure rate in this
study.
Morbid obesity is a chronic and evolving disease, for
which one single surgical intervention is unlikely to pro-
vide definitive relief in all the patients. Each surgical pro-
cedure, however, places the patient at risk for complica-
tions. We agree that the risks of a port revision under local
anesthesia are minimal, but those of laparoscopic band
repositioning or replacement under general anesthesia are
certainly higher, with a non-negligible risk of further com-
plication leading to further revisional surgery. Conversion
Fig. 4 Evolution of BMI in an “intention-to-treat” analysis. Compar-





Type of complication Lapband SAGB p value
Pouch dilatation/slippage 13 (14.4 %) 0 (0 %) <0.001
Band erosion 9 (10 %) 11 (12.2 %) 0.81
Severe GERD/late food intolerance 17 (18.9 %) 18 (20 %) 1.0
Esophageal dilatation/dysmotility 20 (22.2 %) 10 (11.1 %) 0.07
Port/tube complications 10 (11.1 %) 8 (8.9 %) 0.80
Others 1 (1.1 %) 9 (10 %) 0.18
Total patients with complication(s) 54 (60 %) 50 (55.5 %) 1.0
Total patients with reoperation 51 (56.7 %) 47 (52.2 %) 0.65
Total patients with major reoperation 45 (50 %) 44 (48.9 %) 0.99
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from GB to Roux-en-Y gastric bypass is a difficult proce-
dure with risks of complications reported to be between 10
and over 30 % [14–21].
While several authors report acceptable early or midterm
results with GB, both in terms of weight loss and morbidity,
many of the available studies present methodological flaws
that make interpretation difficult. Very often, the follow-up
rate decreases significantly over time and only a small per-
centage of patients have reached the last term in the study.
Another problem is the constant addition of new patients to a
series, sometimes even in progressively increasing numbers,
so that the average duration of follow-up is short even if some
patients have been followed for 10 years. This creates a
dilution effect of the long-term complications and may give
the false impression that they are not very common unless the
group with longer follow-up is analyzed separately. In a recent
study, the outcomes of GB during a 3-year period were eval-
uated at US academic centers [22]. In a cohort of >10,000
patients, the revision and explantation rates both were <1 %
during the study period, two very low figures. This analysis,
however, was based only on hospital records during a 3-year
period during which the number of operated patients increased
considerably. Furthermore, interventions performed at other
hospitals were not captured. With a short mean follow-up, the
real picture is most certainly underestimated. In 2010,
Weichman et al. reported on a large group of patients submit-
ted to GB, with a very low early morbidity of 1.5 %, accept-
able weight loss of between 45 and 50 % up to 6 years and a
10 % long-term complication rate. Unfortunately, their long-
term follow-up rate was very low (29% at 5 years), preventing
meaningful conclusion [23].
GB has been an evolving operation, but its basic princi-
ple—providing adjustable food restriction by an adjustable
band place around the proximal stomach—has remained the
same since almost 20 years. The technique of band implanta-
tion has shifted from the originally described perigastric tech-
nique to the now widely (but not yet uniformly) accepted pars
flaccida technique. The device itself has evolved over time.
The Lapband® and the SAGB® that were used in this study
more than 10 years ago are no longer available and have now
been replaced by newer devices. Some of the advantages of
the modifications seen during the past decade have clearly
been demonstrated like a marked reduction in the posterior
pouch dilatation/slippage rates with the pars flaccida tech-
nique [8]. Symmetrical pouch dilatation, however, remains a
problem [24], and a recently published report from Australia
showed similar overall long-term complication rates between
patients operated with the perigastric or the pars flaccida
technique [11]. Other potential benefits of the newer devices
will require long-term surveillance before definitive conclu-
sions can be drawn.
Like for many other bariatric procedures, there is a
paucity of reports on long-term results after GB. Series
with ≥5-year results are scarce and those with ≥10 years
are exceptional. O'Brien et al. recently published long-term
results up to 16 years in their cohort of 3,227 patients
operated between 1993 and 2011 [11]. The long-term
EBMIL was around 47 % beyond the 10-year term, which
is clearly less than the 66 % reported by Higa et al. [13] or
the 62 % observed currently by ourselves (unpublished
data) 10 years after Roux-en-Y gastric bypass (RYGBP).
An impressive number of patients required revisional sur-
gery even among those operated with the pars flaccida
technique. The need for revision decreased during the most
recent period, but the mean duration of follow-up does not
exceed 3 years, which makes comparison difficult. Another
series with long-term results has been published by
Himpens et al. [25], who reported on a group of 151 with
a follow-up rate of 54 % after 12 years. The mean excess
weight loss (EWL) in the 70 available patients was 42.8 %,
but differed markedly between patients who retained their





Type of reoperation Lapband (A) SAGB (B) p value
Tube/port procedure 10 (11.1 %) 9 (10 %) 0.99
Isolated band removal 10 (11.1 %) 11 (12.2 %) 0.99
Band change 1 (1.1 %) 0 (0 %) 1
Conversion to RYGBP 35 (38.9 %) 32 (35.5 %) 0.75
Total patients with reoperation 51 (56.7 %) 47 (52.2 %) 0.65
Total patients with major reoperation 45 (50 %) 44 (48.9 %) 0.99
Fig. 5 Failure rate over time, combining patients who required band
removal with those who did not achieve an EBMIL of 25 %.
**p <0.01; *p <0.05
OBES SURG (2014) 24:114–122 119
and those who underwent conversion to RYGBP (64 %).
Close to 60 % of patients required at least one reoperation,
and band removal was necessary in 50 % of the case, a figure
very similar to ours. The authors concluded that GB appeared
to result in relatively poor long-term outcomes. Another recent
report from Belgium described outcomes with the SAGB
implanted using the pars flaccida technique [26]. In 745
patients, with a follow-up rate of 88 % after 8 years, the mean
EWLwas 46%. A total of 319 reinterventions were necessary
in 234 patients (31.4 %), and 24 % of the patients had their
band removed after a mean of 7 years. For the authors, this
high reoperation rate did not allow supporting GB as the first-
line surgical option for morbid obesity. Lanthaler et al. also
recently published their long-term results in a series of 276
patients with a follow-up of at least 9 years and considered
their results as disappointing [27]. One hundred forty-six
patients (53 %) developed a total of 190 complications requir-
ing 220 reoperations. At the end of the study period, only 148
patients (53.6 %) still had their original band in place and
another 49 (17.8%) had their band changed at some time, with
acceptable EWL after 10 years. The remaining 79 patients
(28.6 %) no longer had a band. We have previously published
our results in a group of 317 patients with a mean follow-up of
74 months: EWL between 50 and 60 % up to 7 years after
surgery in patients who retain their band, success rate (EWL
≥50 %) of 43 % and failure rate (EWL <25 % or band
removal) of 37 % after 7 years [28]. Balsiger et al., with a
major 7-year complication rate of 32 % in a group of 196
patients, concluded that procedures other than GB, mainly
Roux-en-Y gastric bypass, should be discussed and offered
to the patients [29]. In a series of 199 patients, Boza et al.
found a 33.6 % long-term complication rate and a failure rate
(EWL <50 %) of 46.3 % at 5 years. They have abandoned the
use of GB in their bariatric armamentarium [14].
Others are more optimistic and still consider GB as an
acceptable first-line procedure for morbidly obese patients
despite high long-term complication and failure rates [11,
30–32]. Many stress the importance of very close patient
follow-up and education, some even introducing the notion
of partnership between the patient and the bariatric team.
Some authors attempt to select patients on the basis of preop-
erative factors, such as anatomic and functional studies of the
upper GI tract [11, 33–37], age/sex/BMI of the patients, or
their willingness to durably modify their eating habits and
their lifestyle [38]. All published series of GB for morbid
obesity include a cohort of patients, variable in size, with
excellent results both in terms of weight loss, and overall
quality of life. These few patients do not develop complica-
tions up to 15 years after surgery. This is also our experience,
but as the years pass, the proportion of patients in this group
diminishes considerably, and it represents a minority of the
whole series of patients beyond the 10-year limit, with no
significant difference between two bands evaluated in this
study (17 versus 16 patients with BMI <30 and no long-term
complication 10 years after implantation, p =NS). All bariatric
operations can be followed by long-term complications,
sometimes even reoperations, but the need for reversal or
conversion to another operation varies between procedures.
It is exceptional after RYGBP, as opposed to GB. Several
comparative studies, in fact, have concluded that RYGBP is
superior to GB in the long term, both in terms of weight loss,
morbidity, and the need for reoperations [39–43].
One of the problems that many GB patients experience is
the limited food tolerance, which tends to worsen over time.
This is very unusual with other bariatric procedures and
notably after Roux-en-Y gastric bypass. When we planned
this randomized trial, one of our hypothesis was that a softer
band, the SAGB®, would lead to better food tolerance than a
hard one like the Lapband®. We have previously shown that
there was no difference in food tolerance at any time point up
to 6 years after surgery between the two bands [44].
One strength of our study is the long duration of follow-up,
which averages 144 months, together with a follow-up rate
exceeding 90 % after 10 years. Also, all patients were evalu-
ated and followed up by a multidisciplinary group, including
specialized dieticians and psychologists, with very regular
follow-up for most patients. Complications, especially those
potentially leading to intra-abdominal revision under general
anesthesia, were first treated conservatively if possible, with
the decision to re-operate made only after failure of initial
therapy and/or persistence of symptoms/weight regain.
On the other hand, this study has a number of limitations.
First, the bands that were used are not available anymore.
Secondly, our study compares two bands implanted with
two different techniques (perigastric and pars flaccida), which
might introduce a bias in the results. Nonetheless, the fact that
no significant difference was found between the two devices
in terms of long-term weight loss or overall complication and
reoperation rates prompts us to conclude that results of GB are
very likely more related to its general concept than to the
implanted device or the surgical technique. In fact, comparing
two bands implanted with two different techniques might also
be considered a strength in this study. Third, our study was not
powered initially to detect differences in long-term complica-
tions or failure rates. A post hoc analysis, however, showed
that 93 patients were needed in each group to detect a 40 %
reduction in long-term major morbidity. Finally, our cohort
includes largely unselected patients, as most series reporting
on long-term results of GB.
Proponents of GB currently claim that better patient selec-
tion, better devices, better surgical technique, together with
improved patient education and aftercare will lead to improved
long-term results with GB. They have failed, so far, to provide
us with convincing long-term results. In the present series, only
patients with a large hiatus hernia ± severe reflux disease were
not offered GB. It is now generally accepted that not every
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patient can adhere to severe food restriction as the one desirable
following gastric banding. Some tend to overeat and vomit/
regurgitate frequently, while others progressively switch to a
soft semiliquid high-energy diet, both leading to complications
and/or poor weight loss/weight regain. Poor adaptation can be
related to the patient (culture, education, and inability to chew
due to dental problems) or to the environment (social and
professional life, time allotted to a meal, etc.). We and others
have shown that some pre-existing conditions, like
gastrooesophageal reflux or oesophageal motility disorders,
especially low lower oesophageal sphincter pressure, could be
associated with poorer outcome [34–37]. Criteria which could
help ruling out patients with known preoperative risk factors
would indeed be very helpful to reduce the high long-term
complication rates after GB. Many groups are currently trying
to select patients, but several years will be required before we
know whether this attitude, together with the use of newer
devices, has a real impact on the long-term overall results.
Conclusions
This randomized controlled trial comparing two different
gastric bands inserted with two different surgical methods
for unselected morbidly obese patients shows no significant
difference in the overall long-term results. We conclude that,
except for posterior slippage, which is seen almost exclusively
with the now outdated perigastric technique, long-term out-
come of GB is more likely to be related to the concept of the
procedure itself than to the type of band or surgical technique.
In unselected morbidly obese patients, overall long-term re-
sults are unsatisfactory both in terms of weight loss as in terms
of a high long-term complication rate. Consequently, GB
should not be offered routinely to unselected morbidly obese
patients. Furthermore, as no clear selection criteria has been
validated yet, patients should be informed about the limita-
tions regarding long-term weight loss and complications and
other surgical options should be discussed as well.
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